ARS Pharmaceuticals IncNASDAQ:SPRY
- LAST PRICE8.2100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots8.0000/ 1
- Ask / Lots10.2600/ 1
- Open / Previous Close0.0000 / 8.2100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SPRY |
|---|---|---|
| 09:32 ET | 10350 | 8.6 |
| 09:34 ET | 1201 | 8.48 |
| 09:36 ET | 1172 | 8.455 |
| 09:38 ET | 100 | 8.44 |
| 09:39 ET | 700 | 8.47 |
| 09:41 ET | 1447 | 8.5 |
| 09:43 ET | 200 | 8.4985 |
| 09:50 ET | 674 | 8.53 |
| 09:54 ET | 1000 | 8.57 |
| 09:56 ET | 1361 | 8.56 |
| 09:57 ET | 800 | 8.57 |
| 10:01 ET | 400 | 8.54 |
| 10:12 ET | 400 | 8.5399 |
| 10:15 ET | 100 | 8.535 |
| 10:24 ET | 768 | 8.51 |
| 10:26 ET | 300 | 8.48 |
| 10:28 ET | 700 | 8.49 |
| 10:30 ET | 1672 | 8.485 |
| 10:32 ET | 1864 | 8.44 |
| 10:35 ET | 100 | 8.47 |
| 10:37 ET | 200 | 8.45 |
| 10:39 ET | 400 | 8.46 |
| 10:42 ET | 200 | 8.47 |
| 10:46 ET | 800 | 8.47 |
| 10:48 ET | 1200 | 8.47 |
| 10:50 ET | 717 | 8.4925 |
| 10:53 ET | 320 | 8.51 |
| 10:55 ET | 300 | 8.475 |
| 10:57 ET | 583 | 8.47 |
| 11:00 ET | 482 | 8.47 |
| 11:02 ET | 100 | 8.46 |
| 11:04 ET | 125 | 8.47 |
| 11:06 ET | 100 | 8.46 |
| 11:08 ET | 688 | 8.44 |
| 11:09 ET | 700 | 8.43 |
| 11:11 ET | 800 | 8.4 |
| 11:13 ET | 100 | 8.4 |
| 11:15 ET | 200 | 8.39 |
| 11:18 ET | 1224 | 8.39 |
| 11:22 ET | 200 | 8.38 |
| 11:24 ET | 100 | 8.38 |
| 11:26 ET | 500 | 8.36 |
| 11:27 ET | 400 | 8.365 |
| 11:29 ET | 900 | 8.365 |
| 11:31 ET | 500 | 8.38 |
| 11:36 ET | 300 | 8.38 |
| 11:40 ET | 2500 | 8.42 |
| 11:44 ET | 2100 | 8.45 |
| 11:45 ET | 910 | 8.44 |
| 11:47 ET | 4213 | 8.39 |
| 11:49 ET | 13278 | 8.4 |
| 11:54 ET | 1000 | 8.44 |
| 11:56 ET | 900 | 8.43 |
| 11:58 ET | 3435 | 8.43 |
| 12:00 ET | 10318 | 8.34 |
| 12:02 ET | 255 | 8.3612 |
| 12:07 ET | 450 | 8.3702 |
| 12:09 ET | 900 | 8.3452 |
| 12:14 ET | 599 | 8.36 |
| 12:16 ET | 3600 | 8.3499 |
| 12:18 ET | 1800 | 8.34 |
| 12:21 ET | 3233 | 8.28 |
| 12:25 ET | 2004 | 8.26 |
| 12:27 ET | 300 | 8.25 |
| 12:30 ET | 4100 | 8.27 |
| 12:32 ET | 800 | 8.26 |
| 12:34 ET | 200 | 8.26 |
| 12:36 ET | 157 | 8.27 |
| 12:38 ET | 1327 | 8.25 |
| 12:39 ET | 21841 | 8.25 |
| 12:41 ET | 200 | 8.25 |
| 12:43 ET | 400 | 8.27 |
| 12:45 ET | 1603 | 8.26 |
| 12:48 ET | 200 | 8.26 |
| 12:56 ET | 1726 | 8.235 |
| 12:57 ET | 5306 | 8.24 |
| 12:59 ET | 1801 | 8.24 |
| 01:01 ET | 491 | 8.235 |
| 01:03 ET | 800 | 8.23 |
| 01:06 ET | 100 | 8.23 |
| 01:08 ET | 1541 | 8.23 |
| 01:10 ET | 100 | 8.24 |
| 01:12 ET | 1290 | 8.22 |
| 01:14 ET | 1416 | 8.25 |
| 01:17 ET | 400 | 8.25 |
| 01:21 ET | 513 | 8.27 |
| 01:24 ET | 200 | 8.25 |
| 01:26 ET | 300 | 8.27 |
| 01:30 ET | 500 | 8.3 |
| 01:32 ET | 982 | 8.31 |
| 01:33 ET | 900 | 8.31 |
| 01:35 ET | 843 | 8.3056 |
| 01:37 ET | 1100 | 8.31 |
| 01:39 ET | 483 | 8.305 |
| 01:42 ET | 200 | 8.31 |
| 01:44 ET | 2422 | 8.3 |
| 01:46 ET | 100 | 8.315 |
| 01:48 ET | 300 | 8.33 |
| 01:51 ET | 200 | 8.32 |
| 01:53 ET | 400 | 8.33 |
| 01:55 ET | 400 | 8.35 |
| 01:57 ET | 691 | 8.34 |
| 02:00 ET | 3097 | 8.37 |
| 02:02 ET | 10399 | 8.44 |
| 02:04 ET | 2373 | 8.4294 |
| 02:06 ET | 1600 | 8.4 |
| 02:08 ET | 100 | 8.405 |
| 02:09 ET | 1696 | 8.33 |
| 02:11 ET | 1600 | 8.345 |
| 02:13 ET | 800 | 8.345 |
| 02:20 ET | 600 | 8.3421 |
| 02:22 ET | 1200 | 8.34 |
| 02:24 ET | 886 | 8.31 |
| 02:26 ET | 482 | 8.3 |
| 02:27 ET | 640 | 8.305 |
| 02:29 ET | 100 | 8.31 |
| 02:31 ET | 900 | 8.3 |
| 02:33 ET | 800 | 8.32 |
| 02:36 ET | 326 | 8.325 |
| 02:38 ET | 300 | 8.33 |
| 02:40 ET | 2200 | 8.33 |
| 02:42 ET | 670 | 8.33 |
| 02:44 ET | 1000 | 8.31 |
| 02:45 ET | 524 | 8.29 |
| 02:47 ET | 648 | 8.27 |
| 02:51 ET | 1200 | 8.27 |
| 02:54 ET | 1698 | 8.265 |
| 02:56 ET | 500 | 8.28 |
| 02:58 ET | 1150 | 8.3 |
| 03:02 ET | 1418 | 8.28 |
| 03:05 ET | 400 | 8.27 |
| 03:07 ET | 6540 | 8.265 |
| 03:09 ET | 1343 | 8.26 |
| 03:14 ET | 100 | 8.27 |
| 03:16 ET | 499 | 8.29 |
| 03:18 ET | 1822 | 8.25 |
| 03:20 ET | 2781 | 8.25 |
| 03:21 ET | 804 | 8.26 |
| 03:23 ET | 120 | 8.26 |
| 03:25 ET | 1000 | 8.22 |
| 03:27 ET | 200 | 8.2 |
| 03:30 ET | 2900 | 8.21 |
| 03:32 ET | 300 | 8.21 |
| 03:34 ET | 500 | 8.21 |
| 03:36 ET | 1150 | 8.2 |
| 03:38 ET | 1000 | 8.21 |
| 03:39 ET | 3820 | 8.215 |
| 03:41 ET | 1376 | 8.21 |
| 03:43 ET | 1300 | 8.19 |
| 03:45 ET | 3803 | 8.19 |
| 03:48 ET | 900 | 8.17 |
| 03:50 ET | 3758 | 8.165 |
| 03:52 ET | 1416 | 8.155 |
| 03:54 ET | 4715 | 8.175 |
| 03:56 ET | 2714 | 8.17 |
| 03:57 ET | 14885 | 8.18 |
| 03:59 ET | 52715 | 8.21 |
Apr 16, 2024
Apr 15, 2024
Apr 11, 2024
Apr 8, 2024
Apr 5, 2024
DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Apr 05, 2024 by Dow Jones
9:30PM ET on Friday Apr 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ARS Pharmaceuticals Inc | 792.3M | -14.4x | --- |
Praxis Precision Medicines Inc | 791.1M | -2.0x | --- |
Tyra Biosciences Inc | 814.1M | -9.6x | --- |
Enliven Therapeutics Inc | 822.9M | -8.1x | --- |
CARGO Therapeutics Inc | 749.1M | -8.0x | --- |
Kyverna Therapeutics Inc | 840.7M | -14.1x | --- |
Company Information
ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression.
Contact Information
- Headquarters
- 11682 El Camino Real, Suite 120SAN DIEGO, CA, United States 92130
- Phone
- 858-771-9307
- Fax
- 845-818-3588
Executives
- Independent Chairman of the Board
- Pratik Shah
- President, Chief Executive Officer, Director
- Richard Lowenthal
- Chief Financial Officer
- Kathleen Scott
- Chief Operating Officer
- Brian Dorsey
- Investor Relations
- Justin Chakma
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $792.3M |
|---|---|
Revenue (TTM) | $30.0K |
Shares Outstanding | 96.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-0.57 |
Book Value | $2.39 |
P/E Ratio | -14.4x |
Price/Sales (TTM) | 26,409.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -225,066.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
